Sale!

PIK3CA by NGS Test

6,000 د.إ

-25%

The PIK3CA by NGS (Next-Generation Sequencing) test is a specialized genetic analysis offered by DNA Labs UAE, aimed at detecting mutations in the PIK3CA gene. This gene plays a crucial role in the regulation of cell growth, and mutations within it are often implicated in various cancers, including breast, colorectal, and endometrial cancers. By leveraging the comprehensive and precise approach of NGS technology, this test can identify even minute alterations in the PIK3CA gene, enabling healthcare professionals to make informed decisions regarding prognosis, targeted therapy, and personalized treatment plans for patients.

The cost of the PIK3CA by NGS test at DNA Labs UAE is 6000 AED. This investment in genetic testing is a critical step towards precision medicine, allowing for more tailored and effective treatment strategies, potentially improving patient outcomes in the battle against cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PIK3CA by NGS Test Cost AED:6000.0

Are you concerned about cancer and want to know if you have PIK3CA mutations? Look no further than DNA Labs UAE. Our PIK3CA by NGS test can provide you with the answers you need. Read on to learn more about the test and its cost.

Test Details

The PIK3CA gene encodes for the p110 subunit of phosphatidylinositol 3-kinase (PI3K), an enzyme involved in cell signaling pathways. Mutations in the PIK3CA gene have been linked to various types of cancer, including breast, ovarian, colorectal, and lung cancer.

At DNA Labs UAE, we utilize next-generation sequencing (NGS) technology to detect PIK3CA mutations in cancer patients. NGS allows for the simultaneous analysis of multiple genes, including PIK3CA, in a single assay. This comprehensive approach ensures accurate and reliable results.

NGS can detect different types of PIK3CA mutations, such as missense, nonsense, frameshift, and splice site mutations. Identifying these mutations is crucial as they can predict the response to targeted therapies that inhibit the PI3K pathway.

For instance, breast cancer patients with PIK3CA mutations may benefit from treatment with PI3K inhibitors like alpelisib or taselisib. Knowing your PIK3CA mutation status can help your healthcare provider determine the most effective treatment plan for you.

Test Name: PIK3CA by NGS Test

Components: Please request collection material

Price: 6000.0 AED

Sample Condition: Peripheral blood (10ml)

Report Delivery: 10-15 days

Method: NGS

Test Type: Genetics

Doctor: General Physician

Test Department: Pre Test Information

Pre Test Information: PIK3CA by NGS can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Why Choose DNA Labs UAE?

When it comes to genetic testing, you want a reliable and trusted laboratory. Here’s why DNA Labs UAE is the right choice for your PIK3CA by NGS test:

  • Accurate and reliable results
  • State-of-the-art NGS technology
  • Experienced and knowledgeable team of geneticists
  • Quick report delivery within 10-15 days
  • Convenient sample collection process
  • Competitive pricing at 6000.0 AED

Don’t wait any longer to get the answers you need. Contact DNA Labs UAE today to schedule your PIK3CA by NGS test and take control of your health.

Test Name PIK3CA by NGS Test
Components Please request collection material
Price 6000.0 AED
Sample Condition Peripheral blood (10ml)
Report Delivery 10-15 days
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information PIK3CA by NGS can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

PIK3CA is a gene that encodes for the p110 subunit of phosphatidylinositol 3-kinase (PI3K), an enzyme involved in cell signaling pathways. Mutations in the PIK3CA gene have been implicated in various types of cancer, including breast, ovarian, colorectal, and lung cancer.

Next-generation sequencing (NGS) can be used to detect PIK3CA mutations in cancer patients. This technology allows for the simultaneous analysis of multiple genes, including PIK3CA, in a single assay. NGS can detect various types of PIK3CA mutations, such as missense, nonsense, frameshift, and splice site mutations.

The detection of PIK3CA mutations by NGS can have important clinical implications, as these mutations can predict the response to targeted therapies that inhibit the PI3K pathway. For example, breast cancer patients with PIK3CA mutations may benefit from treatment with PI3K inhibitors, such as alpelisib or taselisib.